相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?
Indranil Dasgupta et al.
HYPERTENSION (2022)
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy
John S. Thurlow et al.
AMERICAN JOURNAL OF NEPHROLOGY (2021)
Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary
A. J. Sinclair et al.
DIABETIC MEDICINE (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Uncertainties in BP management in dialysis patients
Timothy W. R. Doulton et al.
SEMINARS IN DIALYSIS (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes
Jingchuan Guo et al.
DIABETES CARE (2019)
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
Yan Xie et al.
KIDNEY INTERNATIONAL (2018)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study
Charalampos Loutradis et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease The AMETHYST-DN Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria
Ian H. de Boer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
Frank A. Holtkamp et al.
EUROPEAN HEART JOURNAL (2011)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP) A Randomized, Controlled Trial
Rajiv Agarwal et al.
HYPERTENSION (2009)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients
T Shoji et al.
KIDNEY INTERNATIONAL (2004)
Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension results of a randomized controlled trial - Results of a randomized controlled trial
JP O'Hare et al.
DIABETES CARE (2000)
分享论文
